articleNeurologyJan 7, 2022HYBRID OA

Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease

SCSzu-Ju ChenCCChieh-Chang ChenHLHsin-Yu LiaoYLYa-Ting LinYWYu-Wei Wu

Research Institute of Radiology

PubMed
Indexed incrossrefpubmed

Abstract

Background and Objectives Short-chain fatty acids (SCFAs) are gut microbial metabolites that promote the disease process in a rodent model of Parkinson disease (PD), but fecal levels of SCFAs in patients with PD are reduced. Simultaneous assessments of fecal and plasma SCFA levels, and their interrelationships with the PD disease process, are scarce. We aimed to compare fecal and plasma levels of different SCFA subtypes in patients with PD and healthy controls to delineate their interrelations and link to gut microbiota changes and clinical severity of PD. Methods A cohort of 96 patients with PD and 85 controls were recruited from National Taiwan University Hospital. Fecal and plasma concentrations of SCFAs…

Citation impact

238
total citations
FWCI
18.28
Percentile
100%
References
48
Citations per year

Authors

9
  • SC
    Szu-Ju ChenCorresponding

    Research Institute of Radiology

  • CC
    Chieh-Chang Chen

    Research Institute of Radiology

  • HL
    Hsin-Yu Liao

    Research Institute of Radiology

  • YL
    Ya-Ting Lin

    Research Institute of Radiology

  • YW
    Yu-Wei Wu

    Research Institute of Radiology

Topics & keywords

Keywords
  • Gut flora
  • Feces
  • Metabolite
  • Plasma levels
  • Disease
  • Case-control study
  • Severity of illness
No related works found for this paper.

Funding